Curis
Mr. Steinkrauss has served as Chief Financial Officer of the company since September 2019. Mr. Steinkrauss joined Curis in August 2016 as Corporate Controller and Senior Director of Finance, and prior to his appointment served as Treasurer and Vice President of Finance.
This person is not in any offices
Curis
Curis is a publicly-traded biotechnology company focused on the development of first-in-class and innovative therapeutics or the treatment of cancer.